| CAT No: | CL-PSRT-03 |
| CAS No: | 741701-25-7 |
| Mol.F: | C58H66N10O9 |
| Mol.Wt.: | 1047.2 |
| Chemical Name: | (3R,6R,9S,12S,15S,19R,20aS)-6-((1H-indol-3-yl)methyl)-9-(4-aminobutyl)-15-benzyl-12-(4-(benzyloxy)benzyl)-1,4,7,10,13,16-hexaoxo-3-phenylicosahydropyrrolo[1,2-a][1,4,7,10,13,16]hexaazacyclooctadecin-19-yl (2-aminoethyl)carbamate |
| Inventory Status: | Custom synthesis |
This impurity is related to Pasireotide Impurity 2 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Pasireotide Impurity 2 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(3R,6R,9S,12S,15S,19R,20aS)-6-((1H-indol-3-yl)methyl)-9-(4-aminobutyl)-15-benzyl-12-(4-(benzyloxy)benzyl)-1,4,7,10,13,16-hexaoxo-3-phenylicosahydropyrrolo[1,2-a][1,4,7,10,13,16]hexaazacyclooctadecin-19-yl (2-aminoethyl)carbamateCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Pasireotide Molecular Formula: C58H66N10O9
Molecular Weight: 1047.2
Storage: Store in a cool, dry place.
| Product Name: | Pasireotide Impurity 2 |
| CAS No: | 741701-25-7 |
| Mol.F.: | C58H66N10O9 |
| Mol.Wt.: | 1047.2 |
Cat. No: CL-PSRT-01
CAS No: 1421446-02-7
Mol. F: C58H66N10O9 : 2(C4H7NO4)
Mol. Wt: 1047.2 : 2(133.1)
Inv. Status: Custom Synthesis
Cat. No: CL-PSRT-02
CAS No: NA
Mol. F: C57H66N10O10
Mol. Wt: 1051.2
Inv. Status: Custom Synthesis
Cat. No: CL-PSRT-04
CAS No: NA
Mol. F: C55H60N8O8
Mol. Wt: 961.1
Inv. Status: Custom Synthesis
Cat. No: CL-PSRT-05
CAS No: NA
Mol. F: C58H66N10O9
Mol. Wt: 1047.2
Inv. Status: Custom Synthesis
Cat. No: CL-PSRT-06
CAS No: NA
Mol. F: C60H68N10O9
Mol. Wt: 1073.3
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: